Details

Published: 19 November 2025

Hits: 497

Emerging research is raising alarm bells about a potentially dangerous combination that has become increasingly common amongst young people: cannabis use paired with excessive gaming. Whilst each activity carries its own mental health risks, scientists warn that together they may create a perfect storm for psychotic disorders, particularly in adolescents and young adults.

Recent studies have independently linked both cannabis use and problematic gaming behaviour to psychosis, schizophrenia, and other serious mental health conditions. Now, researchers are examining how these two behaviours interact and why the combination appears to pose amplified risks to vulnerable individuals.

The findings carry urgent implications as cannabis legalisation expands and gaming becomes ever more immersive and time-consuming. Understanding the cannabis and gaming risks is crucial for parents, young people, and healthcare providers navigating this evolving landscape.

The Science Behind Cannabis-Related Psychosis

Cannabis has long been associated with increased risk of psychotic disorders, but recent research has provided clearer insights into the mechanisms involved. A groundbreaking study published in JAMA Psychiatry in April 2025 found that cannabis use disorder is associated with heightened dopamine activity in the same brain pathway involved in psychosis.

This discovery helps explain why cannabis increases psychosis risk at a neurochemical level. The dopamine system, which plays crucial roles in motivation, reward, and reality perception, becomes dysregulated with heavy cannabis use. This dysregulation can trigger psychotic symptoms including hallucinations, delusions, paranoia, and disorganised thinking.

National Institutes of Health data indicates that young men who use marijuana face the highest risk of developing psychotic illnesses like schizophrenia. The developing adolescent brain appears particularly vulnerable to cannabis’s effects, with early use linked to more severe long-term consequences.

A September 2025 study published in the Journal of Psychiatric Research compared psychotic symptoms amongst non-cannabis users, natural cannabis users, and synthetic cannabinoid users. The results were striking: synthetic cannabinoid users experienced the most severe psychotic symptoms, high dissociative symptoms with little improvement over time, and limited recovery from alexithymia (difficulty identifying and expressing emotions).

Natural cannabis users showed elevated dissociation with some improvement, whilst non-users demonstrated higher negative symptoms initially but progressive improvement over six months. The researchers concluded that synthetic cannabinoids are associated with “more severe and persistent psychotic symptoms and emotional dysregulation compared to natural cannabis.”

Gaming Disorder and Mental Health

Gaming disorder, recognised by the World Health Organisation as an addictive behavioural disorder, has emerged as a significant mental health concern. A June 2023 study published in the journal Psychopathology examined the link between gaming disorder and psychotic disorders, noting a significant lack of research on how these conditions interact.

The study found that excessive gaming may act as a trigger for psychotic episodes in some patients, based on multiple case reports. Surprisingly, the sudden disruption of gaming habits could also trigger psychosis, suggesting complex relationships between gaming behaviour and mental health.

A 2023 study in BMC Psychiatry identified insomnia and cyberbullying as key mechanisms linking gaming to psychotic disorders. The researchers concluded that preventing sleep deprivation and cyberbullying can reduce psychosis risk, highlighting how gaming’s impacts extend beyond screen time itself.

Research published in Frontiers in Psychiatry in 2024 found that adolescents and young adults engage in “problematic gaming” much faster than adults. These younger gamers also showed similar psychiatric comorbidities including autism, ADHD, and problematic gambling behaviours.

The speed at which young people develop problematic gaming patterns is concerning. Their developing brains, still forming crucial neural pathways and regulatory systems, appear more susceptible to gaming’s addictive properties and associated mental health impacts.

Why the Combination Amplifies Risk

Whilst research specifically examining cannabis and gaming risks together remains limited, mental health professionals warn that the combination creates particularly dangerous conditions for psychosis development.

Psychotherapist Jonathan Alpert explains that both marijuana use and heavy gaming can “tax the brain in similar ways.” Cannabis has been linked to heightened psychosis risk, especially in younger people or those with family histories of mental illness. Gaming, when excessive, disrupts sleep, increases social isolation, and creates cycles of stress and withdrawal.

“When these habits occur together, the risks can multiply,” Alpert warns. “Poor sleep, altered brain chemistry, and detachment from real-world coping skills can converge to increase vulnerability to paranoia, distorted thinking or even psychotic episodes.”

The lifestyle surrounding these habits compounds the problem. Late nights, poor diet, lack of exercise, and limited face-to-face interaction all strain the brain further. “The result is higher risk for psychosis and also weakened overall mental health,” Alpert notes.

Both activities affect similar neurological systems. Cannabis alters dopamine pathways whilst gaming triggers dopamine releases through reward mechanisms. This dual manipulation of the brain’s reward system may create heightened vulnerability to dysregulation.

Sleep disruption represents another critical factor. Cannabis can interfere with sleep architecture, reducing REM sleep and affecting sleep quality. Gaming, particularly late at night, similarly disrupts normal sleep patterns. The combination often leads to severe sleep deprivation, itself a risk factor for psychotic symptoms.

Social isolation amplifies these risks. Heavy gamers often withdraw from real-world relationships, spending increasing time in virtual environments. Cannabis use can increase paranoia and social anxiety, further driving isolation. Together, they create a feedback loop of withdrawal from healthy social connections that normally buffer against mental health problems.

Real-World Consequences

The theoretical risks of cannabis and gaming have manifested in tragic real-world events. Several recent violent incidents have involved perpetrators who combined heavy cannabis use with excessive gaming, particularly violent video games.

In Minneapolis, the gunman in a mass shooting at Annunciation Catholic Church reportedly worked at a cannabis dispensary and “smoked it all the time,” according to friends. In Dallas, an ICE facility shooter was described by friends as “obsessed with sitting at home, smoking weed, playing video games.” He had reportedly logged more than 10,000 hours of gaming, much of it violent shooting games.

Another case involved a suspect who logged nearly 5,000 hours of solo gameplay before allegedly committing an assassination. These cases don’t prove causation, but they highlight concerning patterns that warrant serious attention.

It’s crucial to note that millions of people game and use cannabis without becoming violent. However, these cases suggest that in vulnerable individuals, particularly those with underlying mental health conditions or genetic predispositions, the combination of cannabis and gaming risks may contribute to catastrophic outcomes.

Age Matters: Young People at Greatest Risk

Research consistently shows that younger individuals face more severe consequences from both cannabis use and gaming. A 2022 NIH-published study found that general substance use in children under 17 years posed greater risk of psychotic-like experiences.

The developing adolescent brain undergoes critical maturation processes, particularly in the prefrontal cortex responsible for decision-making, impulse control, and reality testing. Cannabis use during this developmental window can disrupt these processes, potentially causing lasting changes.

Similarly, young people appear more susceptible to gaming’s addictive properties and associated mental health impacts. They develop problematic gaming patterns faster than adults and show higher rates of psychiatric comorbidities.

“Developing early detection and intervention for both substance use and psychotic-like experiences may reduce long-term adverse outcomes,” researchers concluded in the 2022 study. This highlights the importance of prevention and early intervention, particularly for adolescents.

Parents, educators, and healthcare providers must recognise that what might seem like typical teenage behaviour, such as gaming for hours whilst using cannabis, could actually represent significant mental health risks requiring intervention.

Synthetic Cannabinoids: An Even Greater Threat

The September 2025 Journal of Psychiatric Research study revealed that synthetic cannabinoids pose substantially greater risks than natural cannabis. Synthetic cannabinoid users experienced more severe psychotic symptoms, high dissociative symptoms with little improvement over time, and limited recovery from emotional regulation difficulties.

Synthetic cannabinoids, often marketed as “spice” or “K2,” mimic THC’s psychoactive properties but with much stronger effects. These manufactured compounds are often significantly more potent than natural cannabis and can trigger severe adverse reactions including psychosis, seizures, and cardiovascular problems.

The persistence of symptoms in synthetic cannabinoid users is particularly concerning. Whilst natural cannabis users showed some improvement in dissociative symptoms over time, synthetic users demonstrated little recovery, suggesting potentially more lasting brain changes.

Young people may encounter synthetic cannabinoids without realising what they’re consuming, particularly in jurisdictions where natural cannabis remains illegal. The heightened risks associated with these substances underscore the importance of education about different cannabis products and their varying dangers.

Warning Signs and Risk Factors

Recognising warning signs of emerging problems is crucial for early intervention. For cannabis use, red flags include increasing tolerance (needing more to achieve the same effect), unsuccessful attempts to cut down, continued use despite negative consequences, and withdrawal symptoms when not using.

Gaming-related warning signs include gaming for increasingly long periods, unsuccessful attempts to reduce gaming time, loss of interest in other activities, continued gaming despite negative consequences, deceiving others about gaming time, and using gaming to escape negative moods.

When cannabis and gaming risks combine, additional warning signs may emerge including severe sleep disruption, increased social withdrawal, paranoid thoughts or behaviours, difficulty distinguishing between gaming and reality, neglect of personal hygiene and health, and deteriorating academic or work performance.

Risk factors for psychosis include family history of psychotic disorders, early cannabis use (particularly before age 16), high-potency cannabis use, frequent or daily use, synthetic cannabinoid use, pre-existing mental health conditions, social isolation, and stressful life circumstances.

Individuals with multiple risk factors require particular vigilance. Someone with a family history of schizophrenia who begins using high-potency cannabis daily whilst gaming excessively faces substantially elevated risk.

The Policy Debate

These findings emerge as the United States considers reclassifying marijuana as a Schedule III drug, touting medicinal benefits of CBD. This policy shift would reflect growing acceptance of cannabis for medical purposes whilst maintaining some regulatory oversight.

However, the research on cannabis and gaming risks highlights the complexity of cannabis policy. Whilst CBD and other cannabinoids may offer genuine medical benefits for certain conditions, recreational cannabis use, particularly by young people, carries serious mental health risks.

Legalisation has increased cannabis potency and accessibility. Today’s legal cannabis products often contain THC concentrations far exceeding what was available decades ago. High-potency products pose greater psychosis risks, yet remain widely available in legal markets.

Some medical professionals argue that legalisation has worsened mental health outcomes. “Legalising cannabis isn’t helping matters, it’s making things worse,” warns Dr Drew Pinsky, pointing to increased cannabis use disorder rates and psychosis cases in legalised jurisdictions.

Balancing potential medical benefits against recreational use risks remains contentious. Clear age restrictions, potency limits, required health warnings, and robust public education represent potential harm-reduction measures, but their effectiveness varies.

Prevention and Intervention Strategies

Given the identified risks, what can be done to protect vulnerable individuals, particularly young people? Prevention must start with education. Young people, parents, and educators need accurate information about cannabis and gaming risks, particularly when combined.

Schools should incorporate mental health and substance use education into curricula, covering not just traditional drugs but also cannabis and behavioural addictions like gaming. This education should be evidence-based, acknowledging both risks and realities without resorting to scare tactics that undermine credibility.

Parents should monitor their children’s gaming habits and substance use without being overly intrusive. Open, non-judgemental conversations about these topics create environments where young people feel comfortable seeking help if problems develop.

Healthcare providers should routinely screen adolescents and young adults for both substance use and gaming behaviours. Early identification of problematic patterns enables intervention before serious consequences develop.

For those already experiencing problems, evidence-based treatments exist. Cognitive behavioural therapy has proven effective for both cannabis use disorder and gaming disorder. Motivational interviewing can help individuals recognise problems and commit to change.

In cases where psychotic symptoms have emerged, prompt psychiatric evaluation is essential. Early intervention in psychosis can significantly improve long-term outcomes. Treatment may include antipsychotic medications, psychotherapy, and addressing underlying substance use or behavioural issues.

Family involvement often enhances treatment effectiveness. Family therapy can address relationship patterns that may contribute to problematic behaviours whilst strengthening support systems crucial for recovery.

Creating Healthier Lifestyles

Beyond addressing cannabis and gaming specifically, promoting overall mental health and healthy lifestyles provides protective benefits. Regular exercise, consistent sleep schedules, nutritious diet, and meaningful social connections all support mental wellbeing and resilience.

Encouraging diverse interests and activities prevents over-reliance on any single behaviour for entertainment or stress relief. Young people with varied hobbies, strong social networks, and healthy coping strategies are less likely to develop problematic gaming or substance use patterns.

Stress management skills represent another crucial protective factor. Teaching young people healthy ways to manage stress, anxiety, and difficult emotions reduces the appeal of cannabis or gaming as escape mechanisms.

Communities can support these efforts by providing accessible recreational facilities, youth programmes, mental health services, and substance use treatment. Creating environments where young people have opportunities for healthy engagement and readily available help when needed represents sound investment in public health.

The Need for More Research

Despite growing recognition of cannabis and gaming risks, researchers note significant gaps in understanding how these behaviours interact. The June 2023 Psychopathology study specifically noted the lack of research on gaming disorder and psychotic disorder interactions.

More research is needed examining the combined effects of cannabis use and gaming on brain development, particularly in adolescents. Longitudinal studies following young people over time could reveal how these behaviours interact and what factors increase or decrease risk.

Research should also examine whether certain types of games pose greater risks. Do violent games contribute more to psychosis risk than other genres? Does the social isolation of solo gaming matter more than the content?

Understanding protective factors is equally important. Why do some individuals use cannabis and game heavily without developing psychosis whilst others do? Identifying resilience factors could inform more targeted prevention efforts.

The researchers behind the September 2025 study emphasised that “these findings underscore the need for targeted interventions addressing emotional regulation and salience processing in cannabis-related psychosis.” This highlights how research should directly inform treatment development.

A Balanced Perspective

Whilst the research on cannabis and gaming risks is concerning, maintaining perspective is important. Millions of people game regularly and use cannabis without developing psychosis or serious mental health problems. The vast majority of gamers and cannabis users will not experience these severe outcomes.

However, for vulnerable individuals, particularly young people with risk factors like family history of mental illness or early cannabis initiation, the risks are genuine and potentially life-altering. “Not that every gamer or cannabis user is at risk, but this cocktail of behaviours creates an unhealthy lifestyle that leaves people far more vulnerable to serious consequences,” notes psychotherapist Alpert.

The goal isn’t to demonise gaming or cannabis use but to ensure people make informed decisions based on accurate risk information. Young people deserve to understand how their choices might affect their mental health, particularly when multiple risk factors combine.

Looking Forward

As society continues grappling with cannabis legalisation and the proliferation of immersive gaming, the research on their combined mental health impacts will only grow more relevant. Policymakers, healthcare providers, educators, and parents must stay informed about emerging evidence and adapt approaches accordingly.

The studies examining cannabis and gaming risks represent important steps toward understanding how modern lifestyle factors interact to influence mental health. By taking these findings seriously and implementing evidence-based prevention and intervention strategies, we can work to protect vulnerable individuals whilst respecting personal autonomy.

For young people already combining heavy cannabis use with excessive gaming, particularly those experiencing concerning symptoms like paranoia, social withdrawal, or difficulty distinguishing reality, seeking professional help is crucial. Early intervention can prevent progression to full psychotic disorders and improve long-term outcomes.

The message is clear: whilst neither gaming nor cannabis use inevitably leads to psychosis, their combination in vulnerable individuals creates heightened risk that warrants serious attention. Understanding and responding to these risks represents an important public health priority in an era of widespread cannabis use and ubiquitous gaming culture. (Source: WRD News)

Details

Published: 05 November 2025

Hits: 536

There’s blood on the hands of an industry that wraps itself in tie-dye and talks of “wellness.” Behind the carefully cultivated image of cannabis as a harmless plant medicine lies a devastating truth: young people who use marijuana face an 87% increased risk of attempting suicide. Not 8%. Not 17%. Eighty-seven percent.

These aren’t numbers conjured by prohibition-era scaremongering. They emerge from a rigorous systematic review and meta-analysis examining 500,408 participants across 18 studies. This is the kind of evidence that would trigger product recalls, congressional inquiries, and public health emergencies if we were discussing any substance without an army of lobbyists and cultural cheerleaders protecting its reputation.

Yet here we are, watching an entire generation’s mental health catastrophe unfold whilst cannabis culture shrugs, dissembles, and counts its profits.

When 87% Isn’t Enough to Matter

Let’s sit with that suicide attempt figure for a moment. An 87% increased risk amongst young cannabis users compared to non-users. Even after researchers adjusted for every conceivable confounding factor (socioeconomic status, family history, other substance use), the risk remained elevated at 80%. For suicidal ideation, the increase stands at 65%.

These are the kinds of risk elevations that pharmaceutical companies would be sued into oblivion for concealing. Yet somehow, when it comes to cannabis and youth suicide, we’re expected to smile politely whilst an industry built on wilful ignorance floods our communities with high-potency products specifically marketed to appeal to young people.

The cognitive dissonance is breathtaking. We claim to care about youth mental health. We wring our hands over rising suicide rates amongst 15 to 29-year-olds, the demographic for whom suicide remains the fourth leading cause of death globally. Then we turn around and normalise, commercialise, and celebrate a substance proven to dramatically increase their risk of suicidal behaviour.

Depression, Anxiety, and Convenient Amnesia

The suicide statistics are merely the most tragic endpoint of cannabis youth mental health harms. Young marijuana users show 51% higher odds of developing depression and 58% increased likelihood of experiencing anxiety. These aren’t subtle correlations requiring statistical gymnastics to detect. They’re blazing red flags visible from space.

Study after study, across multiple countries and methodologies, tells the same story: early cannabis initiation correlates with subsequent mental health deterioration. The earlier young people begin using, the earlier depressive symptoms emerge. As frequency increases (from occasional to weekly to daily use), mental health outcomes spiral downward with grim predictability.

But don’t expect cannabis culture to acknowledge any of this. Their playbook, borrowed wholesale from Big Tobacco’s greatest hits, involves manufacturing doubt, cherry-picking data, and dismissing inconvenient research as “reefer madness.” When confronted with evidence of harm, they pivot to legalisation talking points, criminal justice reform, or whatever rhetorical smokescreen proves most expedient.

The Neuroscience They’d Rather You Ignore

Here’s what actually happens when adolescents (whose brains won’t fully mature until their mid-twenties) consume cannabis regularly: THC disrupts cannabinoid receptor type 1 (CBR1), triggering a cascade of neurological interference. Nerve impulse transmission falters. Intraneuronal connectivity suffers. The production of neuronal growth factors essential for synapse formation gets disrupted during the most critical period of brain development.

Neuroimaging studies have documented grey matter loss in specific brain regions amongst chronic cannabis users. These are structural changes associated with psychiatric and mood disorders. This isn’t speculation. It’s observable, measurable damage to developing brains.

Yet the cannabis industry continues peddling its “natural” and “harmless” mythology, as though something being plant-derived renders it incapable of harm. By that logic, hemlock makes an excellent salad ingredient and belladonna belongs in your smoothie.

The Self-Medication Lie

When pressed about the risks linking cannabis and youth suicide, advocates often deploy the “self-medication” defence: vulnerable young people use marijuana to cope with pre-existing mental health challenges, they argue, creating a chicken-and-egg scenario that conveniently absolves cannabis of culpability.

Even if we accept this framing (and the evidence suggests it’s only part of the picture), it hardly exonerates the substance. What kind of “medicine” increases suicide attempt risk by 87%? What manner of “therapy” exacerbates the very conditions it purports to treat?

The self-medication narrative actually reveals cannabis culture’s profound cynicism. They’re essentially admitting that psychologically distressed teenagers and young adults are turning to their product, then shrugging when those same young people experience worsened outcomes. It’s the equivalent of selling alcohol to someone drowning and calling it a flotation device.

A Twenty-Billion-Dollar Lie

Global cannabis sales continue their meteoric rise, with legalisation spreading across Canada, multiple US states, Germany, Malta, Thailand, and South Africa. Consumption has surged 20% over the past decade. Marketing budgets rival those of major consumer brands. Product innovation (edibles, vapes, concentrates with THC levels our grandparents couldn’t have imagined) proceeds at breakneck pace.

And through it all, the industry maintains its pose of wounded innocence. According to them, they’re just providing what the people want. They’re correcting historical injustices, they insist. A safer alternative to alcohol is what they’re offering. Consumer choice is being respected.

What they’re actually doing is replicating every cynical strategy that allowed tobacco companies to hook generations of customers whilst denying the mounting evidence of harm. The difference is that cannabis has successfully cloaked itself in progressive politics and counterculture credibility, making it somehow gauche to point out that their products are destroying young people’s mental health and, in the most tragic cases, contributing to their deaths.

The Studies They Won’t Discuss

By 2021, 46% of countries identified cannabis as the predominant substance associated with drug abuse disorders. Thirty-four percent cited marijuana as the primary reason individuals sought treatment for substance abuse. These figures represent a global crisis hiding in plain sight.

Cannabis Use Disorder (CUD) rates are climbing, with adolescents proving particularly vulnerable. Those who develop CUD show even higher rates of depression, anxiety, and suicidal behaviour. It’s a vicious cycle that begins with “just trying it” and ends with grey matter loss and psychiatric disorders.

The research demonstrates clear dose-response relationships: more frequent cannabis consumption correlates with worse mental health outcomes. Daily users report intensified feelings of burdensomeness, thwarted belonging, and suicidal ideation. New consumption methods like vaping (marketed with the same sophisticated techniques that made Juul so devastatingly effective amongst teenagers) appear to amplify these risks.

Yet somehow, amidst this tsunami of evidence, cannabis culture has convinced itself and much of the public that marijuana is essentially harmless. It’s a marketing triumph and a public health catastrophe.

The Gender Gap They Ignore

Even the research landscape reveals telling gaps. Whilst most studies include mixed-gender samples, only a minority provide sex-disaggregated results. This matters enormously, given evidence that women with Cannabis Use Disorder exhibit higher prevalence of mood and anxiety disorders compared to men.

But conducting thorough, gender-specific research might reveal inconvenient truths. Better to maintain strategic ambiguity, continue the broad-brush reassurances, and avoid drilling down into the specific mechanisms of harm.

Profiting from Pandemic Trauma

The COVID-19 pandemic intensified mental health challenges amongst young people: daily disruptions, health anxieties, isolation, bereavement. In any sane response to this suffering, we’d be doing everything possible to protect vulnerable youth from substances that worsen mental health outcomes.

Instead, cannabis companies saw opportunity. Market expansion continued unabated. Product development accelerated. The push to normalise marijuana consumption amongst ever-younger demographics intensified.

When the dust settles on this era, when we finally acknowledge the full scope of cannabis youth mental health harms, we’ll look back with horror at how an industry was permitted to exploit a generation’s trauma for profit.

The Frequency Trap

The pattern is grimly consistent: occasional use leads to weekly use, weekly use escalates to daily use, and daily use correlates with the most severe mental health outcomes. Young people aren’t being told this. They’re being told cannabis is medicine, that it’s natural, that it’s safer than alcohol.

No one tells them that daily cannabis use intensifies feelings of hopelessness and social disconnection, the very psychological states that lead to suicidal crises. No one tells them that as THC potency increases, with today’s products vastly stronger than those from a decade ago, the psychiatric risks rise as well.

The cannabis industry knows all of this. They employ researchers, monitor studies, track trends. Their ignorance isn’t innocent. It’s calculated.

Beyond Doubt

The systematic review examining cannabis youth mental health outcomes encompassed over half a million participants. The methodology was rigorous. The findings were consistent across different study designs, countries, and time periods. This isn’t preliminary data requiring cautious interpretation. It’s evidence demanding urgent action.

Yet cannabis advocates continue their evidence-denying rampage, dismissing research that doesn’t support their narrative whilst trumpeting any study (however methodologically flawed) that suggests potential benefits. It’s the same playbook tobacco companies used for decades, the same cynical manipulation of scientific discourse in service of profit.

What We Owe Young People

Young people deserve honesty. They need adults who will prioritise their mental health and survival over cultural trends, political posturing, and corporate profits. We must also protect them from an industry that treats their developing brains as acceptable collateral damage in the pursuit of market share.

Most urgently, we owe them recognition of what the evidence actually shows: cannabis consumption amongst young people correlates with dramatically increased risks of depression, anxiety, suicidal ideation, and suicide attempts. The 87% increased risk of suicide attempts isn’t a statistical artifact or a coincidence requiring elaborate alternative explanations. It’s a screaming alarm that we’re choosing to ignore.

The Reckoning to Come

History won’t be kind to this moment. Future generations will look back and ask how we knew (how the evidence was this clear, this consistent, this damning) and did nothing. How we allowed an industry to market psychoactive substances to vulnerable young people whilst their lobbyists wrapped themselves in social justice rhetoric and their accountants counted the profits.

They’ll ask why, in an era supposedly concerned with youth mental health, we simultaneously normalised a substance proven to increase suicide risk. Who benefited from our collective amnesia and who paid the price will be another question demanding answers.

The answers will be uncomfortable. The cannabis industry benefited. So did cannabis culture. Politicians seeking easy tax revenue profited as well. Meanwhile, young people (an entire generation of young people) paid with their mental health and, in the most heartbreaking cases, with their lives.

Choosing Courage Over Comfort

Challenging cannabis orthodoxy invites predictable pushback. The accusations are as reliable as they are tedious: prohibitionist, alarmist, anti-science. Never mind that the science actually supports concerns about cannabis and youth suicide. Never mind that the systematic reviews and meta-analyses tell a consistent story of harm.

Cannabis culture has perfected the art of deflection. When confronted with evidence of psychiatric risks, they pivot to criminal justice reform. Studies showing increased suicide risk are dismissed with claims that correlation isn’t causation. Neuroimaging revealing structural brain changes? Researchers must be biased, they say.

It’s exhausting. It’s also beside the point.

The question isn’t whether cannabis should be legal for adults or whether cannabis prohibition was unjust. The question is whether we’re willing to acknowledge that young people who use marijuana face dramatically elevated mental health risks, including an 87% increased likelihood of attempting suicide.

The evidence says yes. Cannabis culture says look over there.

The Bodies Left Behind

Behind every statistic is a young person whose life was cut short or irrevocably altered. That 87% increased suicide attempt risk represents actual teenagers and young adults who didn’t need to die. The elevated rates of depression (51% higher odds) and anxiety (58% increased likelihood) translate to students who dropped out, careers that never launched, relationships that never formed.

These aren’t abstract numbers. They’re someone’s child, someone’s sibling, someone’s friend. They deserved better than to be sacrificed to an industry that values profit over human life and a culture that values being seen as progressive over protecting the vulnerable.

The systematic review examining cannabis and youth suicide provides evidence we can no longer ignore. Young cannabis users face dramatically elevated risks for depression, anxiety, suicidal ideation, and suicide attempts. The dose-response relationships are clear. The neurological mechanisms are documented. The consistency across studies is undeniable.

What remains unclear is whether we possess the courage to act upon this evidence or whether we’ll continue pretending everything is fine whilst young people die.

Cannabis culture wants us to believe this is complicated, that more research is needed, that we’re scapegoating a harmless plant. It’s not complicated. The research exists. And the plant is demonstrably not harmless when consumed by developing brains.

The Evidence Cannot Be Ignored

Studies published between 2013 and 2025, examining periods ranging from one month to 40 years, paint a consistent picture. Whether prospective longitudinal studies, retrospective analyses, or cross-sectional research, the pattern holds. The meta-analysis included data from countries including the United States, Canada, the United Kingdom, New Zealand, Australia, Ukraine, and Mexico. Different populations, different methodologies, same conclusion.

After adjustment for gender, age, ethnicity, living situation, education, employment, and other drug consumption, the elevated risks remained. This isn’t confounding. This isn’t coincidence. This is causation screaming to be acknowledged.

The odds ratios speak for themselves. Depression: 51% higher in cannabis users, 28% even after adjustment. Anxiety: 58% increased odds. Suicidal ideation: 50% to 65% higher depending on the model. Suicide attempts: 87% unadjusted, 80% adjusted.

These numbers represent individual human tragedies multiplied across hundreds of thousands of young lives. They represent families destroyed, potential unrealised, futures stolen. They represent the price we’re paying for allowing an industry to prioritise profits over the wellbeing of an entire generation.

The Industry’s Playbook

The cannabis industry has learned well from its predecessors. When tobacco companies faced mounting evidence of harm, they didn’t admit fault. Tobacco companies funded counter-research and emphasised personal choice. When confronted with evidence, they questioned the science, then delayed, deflected, and denied until the body count became impossible to ignore.

Cannabis companies are following the same script. Cannabis companies fund studies designed to find benefits and emphasise adult choice whilst their marketing clearly targets youth. When results don’t suit them, they question the methodology. Hiding behind progressive rhetoric, the industry continues building an addiction-for-profit empire.

The difference is that we’ve seen this playbook before. We know where it leads. We know how it ends. Yet somehow, we’re permitting the same tragedy to unfold with marijuana consumption amongst young people, wrapped in different packaging but delivering identical results: corporate profits built on human suffering.

What Honesty Demands

The evidence demands we abandon comfortable fictions about cannabis being harmless, natural, or therapeutic for young people. The systematic review encompassing over half a million participants presents findings too consistent to dismiss, too significant to downplay.

We need open, honest discussions about cannabis and youth suicide, without the spin of commercial interests or cultural agendas. Those in power should put young people’s wellbeing ahead of profit. Schools, parents, and communities must also share the plain facts about marijuana’s risks, especially its links to suicide and serious mental illness.

Most urgently, we need to question why, in an era supposedly concerned with youth mental health, we’re simultaneously normalising a substance that increases suicide attempt risk by 87%. The cognitive dissonance is staggering.

A Final Question

The only question left is: how many more young lives will we allow cannabis industry profits to claim before we finally say enough?

The research is unequivocal. Young cannabis users face 87% higher risk of suicide attempts. Young cannabis users experience 51% higher odds of depression and show a 58% greater likelihood of anxiety. Their rates of suicidal ideation rise by 65%, revealing just how severe the mental health risks truly are. These aren’t marginal increases. These are catastrophic elevations in harm.

Cannabis culture will continue manufacturing doubt. The industry will keep counting profits. Lobbyists will keep spinning narratives. But the evidence won’t change. The dead won’t come back. And history will record our choice: profits or young lives.

We know which one cannabis culture has chosen. The question is which one the rest of us will choose.

(Source: WRD News) 

Details

Published: 01 November 2025

Hits: 301

Key Points

Question  What is the size of the placebo response in cannabinoid trials for clinical pain, and is the magnitude of placebo response associated with media attention on the trials?

Findings:  This meta-analysis of 20 studies of 1459 individuals found a significant pain reduction in response to placebo in cannabinoid randomized clinical trials. Media attention was proportionally high, with a strong positive bias, yet not associated with the clinical outcomes.

Meaning:  These findings suggest that placebo has a significant association with pain reduction as seen in cannabinoid clinical trials, and the positive media attention may shape placebo responses in future trials.

Abstract

Importance:  Persistent pain is a common and disabling health problem that is often difficult to treat. There is an increasing interest in medicinal cannabis for treatment of persistent pain; however, the limited superiority of cannabinoids over placebo in clinical trials suggests that positive expectations may contribute to the improvements.

Objective:  To evaluate the size of placebo responses in randomized clinical trials in which cannabinoids were compared with placebo in the treatment of pain and to correlate these responses to objective estimates of media attention.

Main Outcomes and Measures:  Change in pain intensity from before to after treatment, measured as bias-corrected standardized mean difference (Hedges g).

Results:  Twenty studies, including 1459 individuals (mean [SD] age, 51 [7] years; age range, 33-62 years; 815 female [56%]), were included. Pain intensity was associated with a significant reduction in response to placebo, with a moderate to large effect size (mean [SE] Hedges g, 0.64 [0.13]; P < .001). Trials with low risk of bias had greater placebo responses (q₁ = 5.47; I² = 87.08; P = .02). The amount of media attention and dissemination linked to each trial was proportionally high, with a strong positive bias, but was not associated with the clinical outcomes.

Conclusions and Relevance:  Placebo contributes significantly to pain reduction seen in cannabinoid clinical trials. The positive media attention and wide dissemination may uphold high expectations and shape placebo responses in future trials, which has the potential to affect the outcome of clinical trials, regulatory decisions, clinical practice, and ultimately patient access to cannabinoids for pain relief. (Source: JAMA Open Network)

Also see

• Cannabis & Pain – Media Hype & the Placebo Reality?
• EXPOSE on CBD Part 2: Take Care with This Cannabinoid – The Problem of Pain
• CBD Not Recommended for Pain – Again (The placebo works)

Details

Published: 01 November 2025

Hits: 289

Key Takeaways 

• Broad temporal and population spectrum on cannabis use & mental health.
• Cannabis linked to depression, anxiety and suicidal tendencies in studies.
• Early cannabis use in youth leads to mental health issues in adulthood.
• Systematic review and meta-analysis updates cannabis mental health risks evidence.

Abstract: Cannabis is the most widely consumed illicit drug globally. In 2021, 46 % of countries identified cannabis as the predominant substance associated with drug abuse disorders, with 34 % indicating it as the primary cause for seeking treatment. Young individuals represent the largest consumer demographic, experiencing substantial negative health effects. Despite extensive research on its mental health impacts, many aspects remain unclear. This study examines cannabis use among young people including anxiety, depression, and suicidal behavior. Studies involving individuals aged 15–30 were included. Data sources included PubMed, Mendeley, Embase, WOS, CINAHL, and Scopus. After screening 6466 articles, 36 met the inclusion criteria, with 18 included in the meta-analysis. These studies were published between 2013 and 2025. The results indicated that the odds of depression were 51 % higher in young cannabis users (OR = 1.51, 95 %CI = 1.23–1.86), decreasing to 28 % after adjustment (aOR = 1.28, 95 %CI = 1.10–1.50). Anxiety showed a 58 % increase (OR = 1.58, 95 %CI = 1.15–2.15). For suicidal ideation, the increase ranged from 50 % in unadjusted models (OR = 1.50, 95 %CI = 1.05–2.14) to 65 % in adjusted models (aOR = 1.65 95 %CI = 1.40–1.93). Finally, the odds of suicide attempt were 87 % higher (OR = 1.87, 95 %CI = 1.25–2.80), remaining elevated at 80 % after adjustment (aOR = 1.80, 95 %CI = 1.30–2.49).

(Complete Research - Source: Science Direct )